Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Liver Diseases

Free Subscription Articles published in Biochem Biophys Res Commun Retrieve available abstracts of 172 articles: HTML format

Single Articles

January 2026
1. RASINENI K, Rajamanickam R, Perumal SK, Osna NA, et al
   Betaine supplementation prevents ethanol-induced disruption of intestinal tight junction integrity and liver inflammation in rats.
   Biochem Biophys Res Commun. 2026;794:152997.
   PubMed     Abstract available
   
   
   December 2025
2. WANG H, Yang Q, Xiang H, Yao L, et al
   Key oxidized lipid metabolites in pancreatic cancer tissue and metastasis based on metabolomics analysis.
   Biochem Biophys Res Commun. 2025;792:152900.
   PubMed     Abstract available
   
   
   
3. YANG S, Ko M, Zhang W, Jeong SM, et al
   Splicing factor SF3B4 promotes mitochondrial glutamine metabolism in hepatocellular carcinoma by regulating GLS1 isoform switching.
   Biochem Biophys Res Commun. 2025;796:153134.
   PubMed     Abstract available
   
   
   
4. ZHU Y, Hu M, Xu R, Zhai J, et al
   TARDBP upregulates GJB2 to promote tumor progression in hepatocellular carcinoma.
   Biochem Biophys Res Commun. 2025;796:153123.
   PubMed     Abstract available
   
   
   
5. SERAMUR ME, Sink S, Reeves TE, Solberg Woods LC, et al
   Pharmacological inhibition of G protein-coupled receptor kinase 5 decreases high-fat diet-induced hepatic steatosis in mice.
   Biochem Biophys Res Commun. 2025;795:153078.
   PubMed     Abstract available
   
   
   November 2025
6. OKURA K, Koyama Y, Nishio T, Kurata Y, et al
   Activated hepatic stellate cells are required for Hippo-YAP activation and functional liver regeneration following portal vein ligation in mice.
   Biochem Biophys Res Commun. 2025;794:153071.
   PubMed     Abstract available
   
   
   
7. SINGH MM, Shahi A, Chaturvedi CP, Rajak S, et al
   Inhibition of histone-lysine N-methyltransferase G9a exacerbates alcoholic steatohepatitis (ASH) in mice.
   Biochem Biophys Res Commun. 2025;794:153072.
   PubMed     Abstract available
   
   
   
8. KONISHI K, Mochimaru Y, Matsumoto A, Katagiri K, et al
   Unconventional protein secretion of La/SSB in liver cancer.
   Biochem Biophys Res Commun. 2025;791:152949.
   PubMed     Abstract available
   
   
   
9. LIN JC, Huang TS, Chen YB, Chen TY, et al
   Nedd4 family interacting protein 1 (NDFIP1) is a novel target of PF-429242 in promoting autophagy in hepatocellular carcinoma cells.
   Biochem Biophys Res Commun. 2025;794:153065.
   PubMed     Abstract available
   
   
   
10. HU Y, Chai D, Geng Q, Chen L, et al
    Polyene phosphatidyl choline injection regulates lipid homeostasis via AKT-PDE3-PKA in mice.
    Biochem Biophys Res Commun. 2025;790:152921.
    PubMed     Abstract available
    
    
    
11. SINGH A, Gupta I, Saha P, Hole A, et al
    Raman spectroscopy for detecting gastric and liver cancer cells that entered a tolerant persistence state to survive cisplatin chemotherapy.
    Biochem Biophys Res Commun. 2025;790:152891.
    PubMed     Abstract available
    
    
    
12. CHEN M, Yao J, Liu Z
    Curcumin ameliorates high-glucose-induced lipid accumulation in HepG2 cells via AMPK activation and mTOR suppression.
    Biochem Biophys Res Commun. 2025;790:152879.
    PubMed     Abstract available
    
    
    
13. ZHOU R, Li Y, Luo L, Wang L, et al
    Deciphering the pharmacological mechanisms of Scutellariae Radix on hepatocellular carcinoma by combining network pharmacology, metabolomics and experimental evaluations.
    Biochem Biophys Res Commun. 2025;792:152918.
    PubMed     Abstract available
    
    
    
14. DONG M, Zhang J, Long L, Wang H, et al
    Establishment of a liver-specific Albumin-Cre recombinase transgenic golden hamster model using gRosa26-Targeted dual-fluorescent reporter system for hepatocyte-specific genetic manipulation.
    Biochem Biophys Res Commun. 2025;792:152912.
    PubMed     Abstract available
    
    
    October 2025
15. HIDALGO I, Ortiz-Flores M, Perez-Duran J, Ceballos G, et al
    Modulation of molecular and serological biomarkers by (-)-epicatechin consumption on a murine model of metabolic dysfunction-associated steatotic liver disease.
    Biochem Biophys Res Commun. 2025;786:152759.
    PubMed     Abstract available
    
    
    
16. FU J, Chen T, Fang X, Zhang S, et al
    Immune cell subsets as therapeutic targets in liver fibrosis: from mechanisms to translational applications.
    Biochem Biophys Res Commun. 2025;785:152682.
    PubMed     Abstract available
    
    
    
17. KAWAKITA I, Honda S, Yamada Y, Tanaka S, et al
    PAGE4, upregulated in a novel iPSC-derived hepatoblastoma model, promotes hepatoblastoma progression.
    Biochem Biophys Res Commun. 2025;790:152824.
    PubMed     Abstract available
    
    
    
18. CHARMANNA SO, Karunakara SH, Srinivasa S, Panchakshari PM, et al
    Dietary short-chain fatty acid Sodium Butyrate orchestrates pro-apoptotic and anti-angiogenic pathways in HCC cells by targeting the novel SND1/hTERT axis.
    Biochem Biophys Res Commun. 2025;784:152651.
    PubMed     Abstract available
    
    
    September 2025
19. ZHAO Y, Wu XQ, Liao SL
    Rutaecarpine alleviates liver fibrosis by modulating the TRPV1/Connexin 43 axis: A study based on transcriptome data, single-cell sequencing data, and cell experiments.
    Biochem Biophys Res Commun. 2025;781:152506.
    PubMed     Abstract available
    
    
    
20. WEI WJ, Lin C, Luo SH, Huang JJ, et al
    FAM3B activates hepatic stellate cells to accelerate hepatic fibrosis by promoting glucose metabolism.
    Biochem Biophys Res Commun. 2025;786:152703.
    PubMed     Abstract available
    
    
    
21. DU A, Ma X, Huang T, Pan H, et al
    Time-series transcriptome profiling of liver regeneration in ALLPS models of mice identifies the Cyp8b1 as a potential target for hepatocyte proliferation.
    Biochem Biophys Res Commun. 2025;785:152690.
    PubMed     Abstract available
    
    
    
22. ZHANG K, Gan Y, Chen Y, Jiang Z, et al
    A multi-biomarker panel for non-invasive diagnosis, risk stratification, subtype identification, and therapeutic targeting in NAFLD: bioinformatics and experimental insights.
    Biochem Biophys Res Commun. 2025;779:152403.
    PubMed     Abstract available
    
    
    
23. KIM MK, Kim H
    The insect peptide CopA3 enhances hepatocyte proliferation by directly binding to PTEN and inhibiting its activity.
    Biochem Biophys Res Commun. 2025;784:152639.
    PubMed     Abstract available
    
    
    
24. DE OLIVEIRA THC, Goncalves GKN
    Complement system: A key player in hepatic ischemia-reperfusion injury.
    Biochem Biophys Res Commun. 2025;783:152580.
    PubMed     Abstract available
    
    
    
25. ZHONG B, Zhu Q, Wei P, Wang X, et al
    TMAO regulates OTUB1-mediated SLC7A11 stability to promote NAFLD progression.
    Biochem Biophys Res Commun. 2025;778:152352.
    PubMed     Abstract available
    
    
    
26. VARLAMOVA EG, Burmistrov DE, Gudkov SV, Rogachev VV, et al
    Comparative analysis of anticancer properties of So and selenium nanoparticles in a thioacetamide-induced HCC model.
    Biochem Biophys Res Commun. 2025;778:152364.
    PubMed     Abstract available
    
    
    
27. SHARMA I, Singh VK, Vyas R, Verma M, et al
    Computational insights into CHST11 and CHST13: homology modeling, molecular docking, and dynamics simulation for novel therapeutic targeting in cancers.
    Biochem Biophys Res Commun. 2025;777:152323.
    PubMed     Abstract available
    
    
    
28. YU CHJ, Rupasinghe HPV
    Elucidating the mechanistic interplay of AMPK and Nrf2 in MASLD: A focus on dietary phytochemical modulation of lipid and redox homeostasis.
    Biochem Biophys Res Commun. 2025;777:152300.
    PubMed     Abstract available
    
    
    
29. XIANG Y, Liang M, Feng M, Peng Y, et al
    Biosafety of hyperbranched polylysine and its regulatory effect on non-alcoholic fatty liver and gut microbiota.
    Biochem Biophys Res Commun. 2025;777:152253.
    PubMed     Abstract available
    
    
    August 2025
30. CHEN Y, Hu X, Dou J, Chen L, et al
    DJ-1 protein ameliorates nonalcoholic fatty liver disease via ER-stress pathway and reduces inflammation.
    Biochem Biophys Res Commun. 2025;776:152175.
    PubMed     Abstract available
    
    
    
31. WANG Z, Wang Y, Zhang J, Yin K, et al
    Multi-omics approaches to explore the therapeutic mechanism for ginsenoside Rg1 against MASLD.
    Biochem Biophys Res Commun. 2025;776:152161.
    PubMed     Abstract available
    
    
    
32. GUNAGAMBHIRE PV, Rudrappa M, Nayaka S
    Myco-nanofabrication of silver nanoparticles from Clonostachys byssicola PSEF1: Characterization, and exploration of its antimicrobial, antioxidant, anti-diabetic, anti-inflammatory and anticancer property on liver cancer cells.
    Biochem Biophys Res Commun. 2025;781:152544.
    PubMed     Abstract available
    
    
    
33. ALQURASHY NN, Yousef MI, El Tabakh MAM, Hussein AA, et al
    Protective role of Monascus red pigment against hydroxyapatite nanoparticle-induced liver injury in rats via modulation of metabolic regulators.
    Biochem Biophys Res Commun. 2025;775:152179.
    PubMed     Abstract available
    
    
    
34. WANG H, Lu J, Chen K, Ma B, et al
    Efficient derivation of immortalized, isogenic cell lines from genetically defined murine hepatoblastomas.
    Biochem Biophys Res Commun. 2025;780:152478.
    PubMed     Abstract available
    
    
    
35. HAN Y, Fan J, Xia W, Dong X, et al
    Folic acid-functionalized PLGA nanomedicines encapsulating echinacoside for liver cancer therapy.
    Biochem Biophys Res Commun. 2025;774:152049.
    PubMed     Abstract available
    
    
    July 2025
36. JIA X, Wang Z, Zhang R, Lin H, et al
    Integrating network pharmacology and transcriptomics to reveal the anti-hepatocellular carcinoma effects of Nigella B via activation of the P38MAPK pathway.
    Biochem Biophys Res Commun. 2025;778:152411.
    PubMed     Abstract available
    
    
    
37. LI Q, Zhang Q, Ren A, Zhang H, et al
    Analysis and verification of potential ferroptosis-related diagnostic markers in the early stage of metabolic dysfunction-associated steatohepatitis.
    Biochem Biophys Res Commun. 2025;779:152406.
    PubMed     Abstract available
    
    
    
38. SAITO Y, Miyakawa S, Ando S, Kasano-Camones CI, et al
    SALL1 functions as a tumor suppressor in hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2025;778:152385.
    PubMed     Abstract available
    
    
    
39. LIU Z, Qian R, Feng Y, Qi R, et al
    Targeting STAT3 by erianin to overcome sorafenib resistance in hepatocellular carcinoma: Integrated network pharmacology with molecular docking, dynamics simulations, and in vitro validation.
    Biochem Biophys Res Commun. 2025;778:152348.
    PubMed     Abstract available
    
    
    
40. KOGA T, Hiromura M, Song Y, Zhao S, et al
    Selenium binding protein 1 (SBP1) suppresses fructose-induced metabolic dysfunction-associated steatotic liver disease.
    Biochem Biophys Res Commun. 2025;770:152013.
    PubMed     Abstract available
    
    
    
41. ZHANG C, Liu F, Xuan W, Tao Y, et al
    Cardiorespiratory fitness-associated gene signature for prognosis in hepatocellular Carcinoma: Computational prediction and in vivo validation.
    Biochem Biophys Res Commun. 2025;777:152312.
    PubMed     Abstract available
    
    
    
42. WANG Y, Shan H, Wu H, Zhang X, et al
    Resveratrol effectively promoted hepatocyte differentiation of hESCs by enhancing mitochondrial function through PGC-1alpha PPARgamma pathway.
    Biochem Biophys Res Commun. 2025;777:152283.
    PubMed     Abstract available
    
    
    
43. FAN M, Wu J, Wu Y, Zhang Y, et al
    SETDB1 decline promotes the resistance to sorafenib via DRP1 phosphorylation-mediated mitochondrial dysfunction in HepG2 cells.
    Biochem Biophys Res Commun. 2025;768:151934.
    PubMed     Abstract available
    
    
    June 2025
44. CHEN JS, Ho CH
    MicroRNA dynamics and networks to liver fibrosis-related genes during hepatic stellate cell activation by agalactosyl IgG and transforming growth factor-beta1.
    Biochem Biophys Res Commun. 2025;777:152269.
    PubMed     Abstract available
    
    
    
45. CHEN H, Meng G, Yang A
    Laminin gamma2 accelerates non-alcoholic fatty liver disease progression by enhancing lipid accumulation and fibrogenesis in hepatocytes.
    Biochem Biophys Res Commun. 2025;777:152266.
    PubMed     Abstract available
    
    
    
46. AI R, Tian M, Sun J, He S, et al
    Mogroside V prevents ethanol-induced hangover and liver damage by reducing oxidative stress, steatosis and inflammation.
    Biochem Biophys Res Commun. 2025;766:151912.
    PubMed     Abstract available
    
    
    
47. LAN P, Xie C, Liu Q, Wang Y, et al
    Integrated network pharmacology and metabolomics to reveal the mechanism of Liangxuetuihuang formula for the treatment of intrahepatic cholestasis.
    Biochem Biophys Res Commun. 2025;776:152160.
    PubMed     Abstract available
    
    
    
48. LI H, Chen J, Guo H, Yang H, et al
    Integrated transcriptomic and proteomic profiling reveals the anti-inflammatory mechanism of dihydroartemisinin in the treatment of acute liver injury by targeting CYBA and CYBB.
    Biochem Biophys Res Commun. 2025;764:151821.
    PubMed     Abstract available
    
    
    May 2025
49. NISHI H, Nakanishi S, Yamanaka D, Takahashi SI, et al
    Apolipoprotein b transcription is driven by ornithine in hepatoma cell lines.
    Biochem Biophys Res Commun. 2025;775:152076.
    PubMed     Abstract available
    
    
    
50. SHI Q, Ren L, Papineau K, Yang X, et al
    Pexidartinib impairs liver mitochondrial functions causing cell death in primary human hepatocytes at clinically relevant concentrations.
    Biochem Biophys Res Commun. 2025;773:152075.
    PubMed     Abstract available
    
    
    
51. KO JH, Jung TW, Pyo MK, Lim DS, et al
    Senkyunolide A mitigates lipid deposition in hyperlipidemic hepatocytes through SIRT6-mediated suppression of oxidative stress and fetuin-A.
    Biochem Biophys Res Commun. 2025;771:152046.
    PubMed     Abstract available
    
    
    
52. CHEN C, Zhang M, Ma XH, Wang CM, et al
    Hepatic stellate cell-derived Delta-like 1 is dispensable for injury-induced liver fibrosis.
    Biochem Biophys Res Commun. 2025;771:152011.
    PubMed     Abstract available
    
    
    
53. ZHAO Y, Xie L, Liu B, Deng Y, et al
    Novel insight into the role of Src family kinases in hepatocellular carcinoma and therapeutic potential.
    Biochem Biophys Res Commun. 2025;772:151970.
    PubMed     Abstract available
    
    
    
54. KUDO J, Hirono H, Ohkoshi S
    Low-frequency, mild-gradient chronic intermittent hypoxia still induces liver fibrogenesis in mice on a high-fat diet.
    Biochem Biophys Res Commun. 2025;761:151744.
    PubMed     Abstract available
    
    
    April 2025
55. FRANZOLIN AML, Fioretto MN, Ribeiro IT, Maciel FA, et al
    Maternal protein restriction compromises hepatic phenotype and antioxidant defense in postweaning male rats, while females exhibit resilience.
    Biochem Biophys Res Commun. 2025;766:151873.
    PubMed     Abstract available
    
    
    
56. QIAN B, Jiang Z, Chen R, Yang T, et al
    Niacin attenuates hepatic ischemia-reperfusion injury via suppression of 15-HETE mediated inflammation.
    Biochem Biophys Res Commun. 2025;766:151891.
    PubMed     Abstract available
    
    
    
57. CHEN T, Zhang H, Shan W, Zhou J, et al
    Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies.
    Biochem Biophys Res Commun. 2025;766:151881.
    PubMed     Abstract available
    
    
    March 2025
58. ZAIED H, Ashmawy MI, Abdel Karim AE, Ghareeb DA, et al
    Berberine-loaded albumin nanoparticles alleviate liver damage in rats by modulating mitochondrial biogenesis and mitochondria-endoplasmic reticulum interactions.
    Biochem Biophys Res Commun. 2025;754:151555.
    PubMed     Abstract available
    
    
    
59. LAI S, Tang D, Feng J
    Mitochondrial targeted therapies in MAFLD.
    Biochem Biophys Res Commun. 2025;753:151498.
    PubMed     Abstract available
    
    
    
60. HE H, Zhu Y, Ji X, Pu S, et al
    The miR-22-5p/Clec4e axis has diagnostic potential in fructose-induced nonalcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2025;753:151496.
    PubMed     Abstract available
    
    
    
61. FILIP R, Belanger E, Chen X, Lefebvre D, et al
    LYPLAL1 enzyme activity is linked to hepatic glucose metabolism.
    Biochem Biophys Res Commun. 2025;759:151656.
    PubMed     Abstract available
    
    
    
62. YE L, Yao Z, Xuan Q, Liu Q, et al
    The impact of sleeve gastrectomy on MASH development by regulating the composition of gut microbiota and metabolic homeostasis.
    Biochem Biophys Res Commun. 2025;752:151466.
    PubMed     Abstract available
    
    
    
63. CHEN KQ, Zeng T, Tang WR, Wang SZ, et al
    Salusin-alpha attenuates lipid accumulation of C57BL/6 mice with Non-alcoholic fatty liver.
    Biochem Biophys Res Commun. 2025;751:151452.
    PubMed     Abstract available
    
    
    February 2025
64. SHEN C, Oh HR, Park YR, Oh S, et al
    Soluble DPP4 promotes hepatocyte lipid accumulation via SOX2-SCD1 signaling and counteracts DPP4 inhibition.
    Biochem Biophys Res Commun. 2025;756:151521.
    PubMed     Abstract available
    
    
    
65. YAN X, Han Q, Wu W, Li H, et al
    ITGA8 deficiency in hepatic stellate cells attenuates CCl(4)-Induced liver fibrosis via suppression of COL11A1.
    Biochem Biophys Res Commun. 2025;756:151522.
    PubMed     Abstract available
    
    
    
66. TAN S, Fu G, Xie Y, Xie X, et al
    HDAC6 deficiency aggravates ductular reactions through aggresome-mediated hepatocyte apoptosis.
    Biochem Biophys Res Commun. 2025;753:151511.
    PubMed     Abstract available
    
    
    
67. LI J, Liu H, Jia Y, Tuniyazi X, et al
    SW033291 promotes liver regeneration after acetaminophen-induced liver injury in mice.
    Biochem Biophys Res Commun. 2025;749:151365.
    PubMed     Abstract available
    
    
    
68. HEMMATI MA, Foroozanmehr B, Fardin A, Yaribeygi H, et al
    Glp-1 mimetic of sitagliptin improved oxidative stress and liver function tests via suppressing NOX-4 enzyme in hepatic tissues of diabetic rats.
    Biochem Biophys Res Commun. 2025;751:151455.
    PubMed     Abstract available
    
    
    
69. ZHANG L, Du FH, Kun KX, Yan Y, et al
    Abscisic acid improves non-alcoholic fatty liver disease in mice through the AMPK/NRF2/KEAP1 signaling axis.
    Biochem Biophys Res Commun. 2025;747:151291.
    PubMed     Abstract available
    
    
    January 2025
70. UEDA K, Oikawa T, Yamada K, Tsubota A, et al
    Serum PKCdelta is a useful biomarker to distinguish hepatocellular carcinoma from other gastrointestinal cancers.
    Biochem Biophys Res Commun. 2025;751:151431.
    PubMed     Abstract available
    
    
    
71. TANIGUCHI A, Watanabe H, Kimura K, Hashiuchi E, et al
    Proline enhances the hepatic induction of lipogenic gene expression in male hepatic fasn reporter mice.
    Biochem Biophys Res Commun. 2025;747:151314.
    PubMed     Abstract available
    
    
    
72. LIANG Y, Chen L, Huang Z, Li Y, et al
    O-GlcNAcylation of progranulin promotes hepatocellular carcinoma proliferation.
    Biochem Biophys Res Commun. 2025;742:151150.
    PubMed     Abstract available
    
    
    
73. SHI Y, Zeng Y, Zuo R, Wu S, et al
    Antimicrobial peptide Mt 5 inhibits human hepatocellular carcinoma cell HepG2 proliferation.
    Biochem Biophys Res Commun. 2025;742:151126.
    PubMed     Abstract available
    
    
    
74. LIU ZM, Zhang YN, Zhang HF, Zhang XY, et al
    Combined PD-1 and IL-10 blockade reinvigorates mucosal CD8(+)T exhaustion and relieves liver damage after intestinal ischemia reperfusion attack.
    Biochem Biophys Res Commun. 2025;742:151137.
    PubMed     Abstract available
    
    
    
75. BAE AN, Lee H, Yang H, Mukherjee S, et al
    Enhancing Regulatory T cell function by mevalonate pathway inhibition prevents liver fibrosis.
    Biochem Biophys Res Commun. 2025;742:151094.
    PubMed     Abstract available
    
    
    
76. MAHARAJAN N, Vijayakumar KA, Cho GW
    Therapeutic potential of the flavonoid compound Licochalcone D in metabolic dysfunction-associated steatotic liver disease.
    Biochem Biophys Res Commun. 2025;744:151216.
    PubMed     Abstract available
    
    
    
77. YU Z, Dong C, Yang Y, Zheng Z, et al
    USP21 stabilizes immune checkpoint of CD276 and serves as an immunological and tumor prognostic biomarker.
    Biochem Biophys Res Commun. 2025;745:151221.
    PubMed     Abstract available
    
    
    December 2024
78. MAVVAJI M, Zeyrek CT, Akkoc S
    Investigation of the cytotoxic activity, DFT calculation, and docking studies newly synthesized 1,3-disubstituted benzimidazolium chlorides on human liver cancer, lung cancer, and normal embryonic kidney cell lines.
    Biochem Biophys Res Commun. 2024;741:151024.
    PubMed     Abstract available
    
    
    
79. UCHIYAMA A, Kon K, Morinaga M, Fukada H, et al
    Palmitic acid induces insulin resistance and oxidative stress-mediated cell injury through accumulation of lipid rafts in murine hepatocytes.
    Biochem Biophys Res Commun. 2024;745:151242.
    PubMed     Abstract available
    
    
    
80. HAO YY, Xiao WQ, Zhang HN, Yu NN, et al
    Peroxiredoxin 1 modulates oxidative stress resistance and cell apoptosis through stemness in liver cancer under non-thermal plasma treatment.
    Biochem Biophys Res Commun. 2024;738:150522.
    PubMed     Abstract available
    
    
    
81. GONG X, Liu Y, Liang K, Chen Z, et al
    Cucurbitacin I exerts its anticancer effects by inducing cell cycle arrest via the KAT2a-ube2C/E2F1 pathway and inhibiting HepG2-induced macrophage M2 polarization.
    Biochem Biophys Res Commun. 2024;738:150508.
    PubMed     Abstract available
    
    
    
82. RAJAK S, Shah A, Yadav A, Shahi A, et al
    Inhibition of histone methyltransferase G9a aggravates phenotypic severity of hepatic lipotoxicity in non-alcoholic steatohepatitis (NASH).
    Biochem Biophys Res Commun. 2024;743:151171.
    PubMed     Abstract available
    
    
    
83. WU J, Liu F, Guo X, Cui C, et al
    FASN promotes anoikis resistance in colorectal liver metastases through the ERK1/2 pathway.
    Biochem Biophys Res Commun. 2024;736:150494.
    PubMed     Abstract available
    
    
    November 2024
84. LEE J, Hong SW, Kim MJ, Lim YM, et al
    Sodium-glucose cotransporter 2 inhibitors ameliorate ER stress-induced pro-inflammatory cytokine expression by inhibiting CD36 in NAFLD progression in vitro.
    Biochem Biophys Res Commun. 2024;735:150620.
    PubMed     Abstract available
    
    
    
85. DU Y, Zhang H, Liu J, Duan X, et al
    HK3: A potential prognostic biomarker with metastasis inhibition capabilities in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2024;741:151057.
    PubMed     Abstract available
    
    
    
86. XU X, Wang Y, Wu X, Cai T, et al
    Administration of Alistipes indistinctus prevented the progression from nonalcoholic fatty liver disease to nonalcoholic steatohepatitis by enhancing the gut barrier and increasing Lactobacillus spp.
    Biochem Biophys Res Commun. 2024;741:151033.
    PubMed     Abstract available
    
    
    
87. LI C, Chen X, Wu J, Heng S, et al
    High-throughput screening identified pacritinib as a promising therapeutic approach to overcome lenvatinib resistance in hepatocellular carcinoma by targeting IRAK1.
    Biochem Biophys Res Commun. 2024;734:150782.
    PubMed     Abstract available
    
    
    
88. YAMAUCHI Y, Mieno H, Suetsugu H, Watanabe H, et al
    Elevated PRELP expression in heart and liver fibrosis promotes collagen production.
    Biochem Biophys Res Commun. 2024;734:150785.
    PubMed     Abstract available
    
    
    
89. ZHAI F, Wang J, Wan X, Liu Y, et al
    Dual anti-inflammatory effects of curcumin and berberine on acetaminophen-induced liver injury in mice by inhibiting NF-kappaB activation via PI3K/AKT and PPARgamma signaling pathways.
    Biochem Biophys Res Commun. 2024;734:150772.
    PubMed     Abstract available
    
    
    
90. LIU X, Liu T, Zhou Z, Bian K, et al
    Brusatol improves the efficacy of sorafenib in Huh7 cells via ferroptosis resistance dependent Nrf2 signaling pathway.
    Biochem Biophys Res Commun. 2024;734:150762.
    PubMed     Abstract available
    
    
    
91. SHAHI A, Yadav A, Rajak S, Raza S, et al
    Liver-specific thyroid hormone receptor-beta agonism alleviates alcoholic steatohepatitis (ASH) in mice.
    Biochem Biophys Res Commun. 2024;734:150742.
    PubMed     Abstract available
    
    
    
92. LI YN, Sun FF, Ouyang F, Luo D, et al
    Alterations in liver triglyceride profiles in CCl(4)-induced liver regeneration.
    Biochem Biophys Res Commun. 2024;734:150662.
    PubMed     Abstract available
    
    
    
93. GAO G, Zhang Z, Wang Q, Xie Z, et al
    A peptide alleviated oxidative damages in the L02 cells and mice liver.
    Biochem Biophys Res Commun. 2024;734:150643.
    PubMed     Abstract available
    
    
    
94. MAO D, Guo J, Yang K, Yang F, et al
    Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation.
    Biochem Biophys Res Commun. 2024;734:150424.
    PubMed     Abstract available
    
    
    
95. TSUCHIYA Y, Nishina T, Komazawa-Sakon S, Seki T, et al
    Interleukin-11 signaling plays limited roles for liver fibrosis in a mouse model of metabolic dysfunction-associated steatohepatitis.
    Biochem Biophys Res Commun. 2024;739:150938.
    PubMed     Abstract available
    
    
    October 2024
96. HU L, Yuan D, Zhu Q, Wu M, et al
    Evaluation of the role of hepatic Gstm4 in diet-induced obesity and dyslipidemia.
    Biochem Biophys Res Commun. 2024;737:150920.
    PubMed     Abstract available
    
    
    
97. EL-ZEHERY IM, El-Mesery M, El-Sherbiny M, El Gayar AM, et al
    Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in rats.
    Biochem Biophys Res Commun. 2024;741:150876.
    PubMed     Abstract available
    
    
    
98. AHN SH, Lee YJ, Lim DS, Cho W, et al
    Upadacitinib counteracts hepatic lipid deposition via the repression of JAK1/STAT3 signaling and AMPK/autophagy-mediated suppression of ER stress.
    Biochem Biophys Res Commun. 2024;735:150829.
    PubMed     Abstract available
    
    
    
99. GULZAR F, Chhikara N, Kumar P, Ahmad S, et al
    ER stress aggravates NOD1-mediated inflammatory response leading to impaired nutrient metabolism in hepatoma cells.
    Biochem Biophys Res Commun. 2024;735:150827.
    PubMed     Abstract available
    
    
    September 2024
100. CHEN Y, Zhang Y, Jin X, Hong S, et al
     Exerkines: Benign adaptation for exercise and benefits for non-alcoholic fatty liver disease.
     Biochem Biophys Res Commun. 2024;726:150305.
     PubMed     Abstract available
     
     
     
101. YU T, Wang L, Cheng Y, Zhang Y, et al
     Downregulation of Setdb2 promotes alternative activation of macrophages via the PI3K/Akt pathway to attenuate NAFLD after sleeve gastrectomy.
     Biochem Biophys Res Commun. 2024;726:150264.
     PubMed     Abstract available
     
     
     
102. MA ZJ, Yue SS, Qin BY, Hu YT, et al
     Naringenin ameliorates MASH fibrosis via regulating TAK1/MAPK/FoxO3a-mediated apoptosis in the activated hepatic stellate cells.
     Biochem Biophys Res Commun. 2024;734:150732.
     PubMed     Abstract available
     
     
     
103. CHOI MS, Hong JS, Lee DH, Lee YS, et al
     MicroRNA miR-199a-3p alleviates liver fibrosis by targeting CDK17 in activated hepatic stellate cells.
     Biochem Biophys Res Commun. 2024;733:150727.
     PubMed     Abstract available
     
     
     
104. SHEN J, Wu Z, Zhou Y, Yang D, et al
     Knockdown of SLC16A3 decreases extracellular lactate concentration in hepatocellular carcinoma, alleviates hypoxia and induces ferroptosis.
     Biochem Biophys Res Commun. 2024;733:150709.
     PubMed     Abstract available
     
     
     
105. MALHEIRO LFL, Oliveira CA, Portela FS, Merces EAB, et al
     High-intensity interval training alleviates liver inflammation by regulating the TLR4/NF-kappaB signaling pathway and M1/M2 macrophage balance in female rats with cisplatin hepatotoxicity.
     Biochem Biophys Res Commun. 2024;733:150712.
     PubMed     Abstract available
     
     
     
106. SON HK, Jhun H, Lee HB, Lee YR, et al
     Influence of different types of dietary sugars on the intestinal mucosa and hepatic lipid metabolism in germ-free mice.
     Biochem Biophys Res Commun. 2024;733:150707.
     PubMed     Abstract available
     
     
     August 2024
107. HE Y, Wu S, Chen L, Chen W, et al
     Constructing and validating pan-apoptosis-related features for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
     Biochem Biophys Res Commun. 2024;734:150633.
     PubMed     Abstract available
     
     
     
108. YAMAGATA K, Takasuga S, Tatematsu M, Fuchimukai A, et al
     FoxD1 expression identifies a distinct subset of hepatic stellate cells involved in liver fibrosis.
     Biochem Biophys Res Commun. 2024;734:150632.
     PubMed     Abstract available
     
     
     
109. HE Y, Long K, Du B, Liao W, et al
     The cellular senescence score (CSS) is a comprehensive biomarker to predict prognosis and assess senescence and immune characteristics in hepatocellular carcinoma (HCC).
     Biochem Biophys Res Commun. 2024;739:150576.
     PubMed    
     
     
     
110. LI J, Wen W, Li J, Liu T, et al
     CNOT7 regulates lipid deposition in nonalcoholic fatty liver disease.
     Biochem Biophys Res Commun. 2024;721:150003.
     PubMed     Abstract available
     
     
     
111. TOMIOKA I, Ota C, Tanahashi Y, Ikegami K, et al
     Loss of the DNA-binding domain of the farnesoid X receptor gene causes severe liver and kidney injuries.
     Biochem Biophys Res Commun. 2024;721:150125.
     PubMed     Abstract available
     
     
     
112. SUN T, Li S, Li X, Lei Y, et al
     Apigenin intervenes in liver fibrosis by regulating PKM2-HIF-1alpha mediated oxidative stress.
     Biochem Biophys Res Commun. 2024;721:150130.
     PubMed     Abstract available
     
     
     
113. ZHOU Y, Song XL, Guo LB, Yu XR, et al
     Avapritinib efficacy in primary hepatic neuroendocrine carcinoma with elevated PDGFRA expression: Insights from a PDX model study.
     Biochem Biophys Res Commun. 2024;736:150504.
     PubMed     Abstract available
     
     
     July 2024
114. ZHU J, Liu Q, Nie S, Huang Y, et al
     LEPR/FOS/JUNB signaling pathway contributes to chronic restraint stress-induced tumor proliferation.
     Biochem Biophys Res Commun. 2024;719:150042.
     PubMed     Abstract available
     
     
     
115. SAVOCA M, Takemoto K, Hu J, Li L, et al
     MitoTracker Red for isolation of zone-specific hepatocytes and characterization of hepatic sublobular metabolism.
     Biochem Biophys Res Commun. 2024;735:150457.
     PubMed     Abstract available
     
     
     
116. MA Y, Yao X, Zou Y, Liu B, et al
     Ticlopidine protects hepatic ischemia-reperfusion injury via suppressing ferroptosis.
     Biochem Biophys Res Commun. 2024;733:150436.
     PubMed     Abstract available
     
     
     
117. YANG M, Wang R, Wei L, Liu H, et al
     PLA plastic particles disrupt bile acid metabolism leading to hepatic inflammatory injury in male mice.
     Biochem Biophys Res Commun. 2024;732:150410.
     PubMed     Abstract available
     
     
     
118. DROPMANN A, Alex S, Schorn K, Tong C, et al
     The TGF-beta1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.
     Biochem Biophys Res Commun. 2024;732:150409.
     PubMed     Abstract available
     
     
     
119. GWON HJ, Chung YH, Lim DS, Cho W, et al
     Uvaol ameliorates lipid deposition in hyperlipidemic hepatocytes by suppressing protein-tyrosine phosphatase 1B/ER stress signaling.
     Biochem Biophys Res Commun. 2024;730:150387.
     PubMed     Abstract available
     
     
     June 2024
120. ZHANG S, Gao YF, Zhang K, Deng GR, et al
     Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.
     Biochem Biophys Res Commun. 2024;715:149999.
     PubMed     Abstract available
     
     
     
121. YAMAMOTO T, Iizuka Y, Izumi-Yamamoto K, Shirota M, et al
     Overexpression of Slc22a18 facilitates fat accumulation in mice.
     Biochem Biophys Res Commun. 2024;712-713:149922.
     PubMed     Abstract available
     
     
     
122. ERITEN B, Caglayan C, Gur C, Kucukler S, et al
     Hepatoprotective effects of zingerone on sodium arsenite-induced hepatotoxicity in rats: Modulating the levels of caspase-3/Bax/Bcl-2, NLRP3/NF-kappaB/TNF-alpha and ATF6/IRE1/PERK/GRP78 signaling pathways.
     Biochem Biophys Res Commun. 2024;725:150258.
     PubMed     Abstract available
     
     
     
123. KIM DH, Kwon EJ, Park KG, Jin J, et al
     Acesulfame potassium upregulates PD-L1 in HCC cells by attenuating autophagic degradation.
     Biochem Biophys Res Commun. 2024;711:149921.
     PubMed     Abstract available
     
     
     May 2024
124. MAO T, Zhang C, Yang S, Bi Y, et al
     Semaglutide alters gut microbiota and improves NAFLD in db/db mice.
     Biochem Biophys Res Commun. 2024;710:149882.
     PubMed     Abstract available
     
     
     
125. LIU X, Liu R, Wang Y
     Indole-3-carboxaldehyde alleviates acetaminophen-induced liver injury via inhibition of oxidative stress and apoptosis.
     Biochem Biophys Res Commun. 2024;710:149880.
     PubMed     Abstract available
     
     
     
126. WANG B, Zhu X, Yu S, Xue H, et al
     Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice.
     Biochem Biophys Res Commun. 2024;722:150170.
     PubMed     Abstract available
     
     
     
127. SHI X, Qi Z, Huang D, Zhu J, et al
     HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3'UTR ARE2 in hepatocellular carcinoma.
     Biochem Biophys Res Commun. 2024;722:150152.
     PubMed     Abstract available
     
     
     
128. ZHU J, Tang W, Wu X, Mu M, et al
     Tectorigenin improves metabolic dysfunction-associated steatohepatitis by down-regulating tRF-3040b and promoting mitophagy to inhibit pyroptosis pathway.
     Biochem Biophys Res Commun. 2024;720:150118.
     PubMed     Abstract available
     
     
     
129. DONG M, Zhang T, Liang X, Cheng X, et al
     Sesamin alleviates lipid accumulation induced by oleic acid via PINK1/Parkin-mediated mitophagy in HepG2 cells.
     Biochem Biophys Res Commun. 2024;708:149815.
     PubMed     Abstract available
     
     
     
130. ZHENG E, Chen Q, Xiao A, Luo X, et al
     Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
     Biochem Biophys Res Commun. 2024;707:149781.
     PubMed     Abstract available
     
     
     April 2024
131. HE L, Peng L, Wang L, Jiang X, et al
     Investigation of folate-modified EGCG-loaded thermosensitive nanospheres inducing immunogenic cell death and damage-associated molecular patterns in hepatocellular carcinoma.
     Biochem Biophys Res Commun. 2024;714:149976.
     PubMed     Abstract available
     
     
     
132. PENG J, Liang G, Li Y, Mao S, et al
     Identification of a novel FOXO3 agonist that protects against alcohol induced liver injury.
     Biochem Biophys Res Commun. 2024;704:149690.
     PubMed     Abstract available
     
     
     
133. CAO Y, Wang S, Zhang M, Lai B, et al
     PFKFB3-mediated glycolysis in hepatic stellate cells promotes liver regeneration.
     Biochem Biophys Res Commun. 2024;712-713:149958.
     PubMed     Abstract available
     
     
     
134. CHEN F
     Inhibiting Pink1/Parkin-mediated mitophagy enhances the anticancer effects of quercetin in hepatocellular carcinomaf.
     Biochem Biophys Res Commun. 2024;712-713:149899.
     PubMed     Abstract available
     
     
     
135. WU M, Tie M, Hu L, Yang Y, et al
     Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1.
     Biochem Biophys Res Commun. 2024;702:149655.
     PubMed     Abstract available
     
     
     March 2024
136. SEYAMA Y, Sudo K, Yamada T, Tsuchiya K, et al
     Ascorbic acid predominantly kills cancer stem cell-like cells in the hepatocellular carcinoma cell line Li-7 and is more effective at low cell density and in small spheroids.
     Biochem Biophys Res Commun. 2024;709:149816.
     PubMed     Abstract available
     
     
     February 2024
137. SHANG S, Wan Q, Chen F, Hu J, et al
     Co-targeting ASK1 and THRbeta synergistically improves steatohepatitis and fibrosis in a MASH animal model.
     Biochem Biophys Res Commun. 2024;705:149739.
     PubMed     Abstract available
     
     
     
138. HUANG W, Qian Y, Lin J, Wang F, et al
     Baicalein alleviates intrahepatic cholestasis by regulating bile acid metabolism via an FXR-dependent manner.
     Biochem Biophys Res Commun. 2024;705:149670.
     PubMed     Abstract available
     
     
     
139. CHO W, Oh H, Abd El-Aty AM, Ozten O, et al
     Interleukin-27 as a novel player in alleviating hepatic steatosis: Mechanistic insights from an in vitro analysis.
     Biochem Biophys Res Commun. 2024;703:149671.
     PubMed     Abstract available
     
     
     
140. KALISHWARALAL K, Azeez Nazeer A, Induja DK, Keerthana CK, et al
     Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling.
     Biochem Biophys Res Commun. 2024;703:149648.
     PubMed     Abstract available
     
     
     
141. YUAN X, Wen Y, Shi Q, Zhao Y, et al
     MicroRNA-148a-3p suppresses the glycolysis and Cell proliferation by targeting transmembrane protein 54 in liver cancer.
     Biochem Biophys Res Commun. 2024;695:149424.
     PubMed     Abstract available
     
     
     January 2024
142. ZHANG M, Shi X, Tang M, Yin W, et al
     PRDX2 deficiency increases MCD-induced nonalcoholic steatohepatitis in female mice.
     Biochem Biophys Res Commun. 2024;701:149589.
     PubMed     Abstract available
     
     
     
143. LI C, Liang G, Yan K, Wang Y, et al
     NRF2 mutation enhances the immune escape of hepatocellular carcinoma by reducing STING activation.
     Biochem Biophys Res Commun. 2024;698:149536.
     PubMed     Abstract available
     
     
     
144. JIN M, Mi Y, Li F, Ren F, et al
     ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression.
     Biochem Biophys Res Commun. 2024;696:149515.
     PubMed     Abstract available
     
     
     
145. LEE S, Memon A, Chae SC, Shin D, et al
     Epcam regulates intrahepatic bile duct reconstruction in zebrafish, providing a potential model for primary cholangitis model.
     Biochem Biophys Res Commun. 2024;696:149512.
     PubMed     Abstract available
     
     
     
146. BAE S, Moon YA
     Deletion of Elovl5 leads to dyslipidemia and atherosclerosis in LDLR-deficient mice.
     Biochem Biophys Res Commun. 2024;690:149292.
     PubMed     Abstract available
     
     
     December 2023
147. ABI ZAMER B, Rah B, Jayakumar MN, Abumustafa W, et al
     DNA methylation-mediated epigenetic regulation of oncogenic RPS2 as a novel therapeutic target and biomarker in hepatocellular carcinoma.
     Biochem Biophys Res Commun. 2023;696:149453.
     PubMed     Abstract available
     
     
     
148. ABDELRAHMAN BA, Hammam OA, El-Khatib AS, Attia YM, et al
     The role of vitamin D3 in modulating the interplay between NLRP3 inflammasome and autophagy in NASH.
     Biochem Biophys Res Commun. 2023;688:149122.
     PubMed     Abstract available
     
     
     
149. ZHAO H, Han G, Jiang Z, Gao D, et al
     Identification of BMAL1-Regulated circadian genes in mouse liver and their potential association with hepatocellular carcinoma: Gys2 and Upp2 as promising candidates.
     Biochem Biophys Res Commun. 2023;696:149422.
     PubMed     Abstract available
     
     
     
150. HORIKOSHI M, Harada K, Tsuno S, Kitaguchi T, et al
     Distinct lactate metabolism between hepatocytes and myotubes revealed by live cell imaging with genetically encoded indicators.
     Biochem Biophys Res Commun. 2023;694:149416.
     PubMed     Abstract available
     
     
     
151. NAMBA N, Kuwahara T, Kondo Y, Fukusaki K, et al
     Fasudil inhibits the expression of C/EBP homologous protein to protect against liver injury in acetaminophen-overdosed mice.
     Biochem Biophys Res Commun. 2023;686:149166.
     PubMed     Abstract available
     
     
     
152. CAO J, Zhong Q, Huang Y, Zhu M, et al
     Identification and validation of INHBE and P4HA1 as hub genes in non-alcoholic fatty liver disease.
     Biochem Biophys Res Commun. 2023;686:149180.
     PubMed     Abstract available
     
     
     
153. IMAMORI M, Hosooka T, Imi Y, Hosokawa Y, et al
     Thrombospondin-1 promotes liver fibrosis by enhancing TGF-beta action in hepatic stellate cells.
     Biochem Biophys Res Commun. 2023;693:149369.
     PubMed     Abstract available
     
     
     
154. QU D, Chen M, Zhu H, Liu X, et al
     Akkermansia muciniphila and its outer membrane protein Amuc_1100 prevent high-fat diet-induced nonalcoholic fatty liver disease in mice.
     Biochem Biophys Res Commun. 2023;684:149131.
     PubMed     Abstract available
     
     
     November 2023
155. HE J, Han J, Lin K, Wang J, et al
     PTEN/AKT and Wnt/beta-catenin signaling pathways regulate the proliferation of Lgr5+ cells in liver cancer.
     Biochem Biophys Res Commun. 2023;683:149117.
     PubMed     Abstract available
     
     
     
156. FENG R, Cheng D, Chen X, Yang L, et al
     Identification and validation of palmitoylation metabolism-related signature for liver hepatocellular carcinoma.
     Biochem Biophys Res Commun. 2023;692:149325.
     PubMed     Abstract available
     
     
     
157. HAN Q, Yan X, Wang L, Zhang N, et al
     Aryl hydrocarbon receptor attenuates cholestatic liver injury by regulating bile acid metabolism.
     Biochem Biophys Res Commun. 2023;682:259-265.
     PubMed     Abstract available
     
     
     
158. SUO L, Gao M, Ma T, Gao Z, et al
     Effect of RPL27 knockdown on the proliferation and apoptosis of human liver cancer cells.
     Biochem Biophys Res Commun. 2023;682:156-162.
     PubMed     Abstract available
     
     
     
159. LIN X, Pan F, Abudoureyimu M, Wang T, et al
     Aurora-A inhibitor synergistically enhances the inhibitory effect of anlotinib on hepatocellular carcinoma.
     Biochem Biophys Res Commun. 2023;690:149247.
     PubMed     Abstract available
     
     
     
160. RAMPOGU S, Badvel P, Hoon Jo B, Kim Y, et al
     A review on Millepachine and its derivatives as potential multitarget anticancer agents.
     Biochem Biophys Res Commun. 2023;681:249-270.
     PubMed     Abstract available
     
     
     
161. WANG S, Yi W, Xu Z, Shi M, et al
     PYCR2 promotes growth and aerobic glycolysis in human liver cancer by regulating the AKT signaling pathway.
     Biochem Biophys Res Commun. 2023;680:15-24.
     PubMed     Abstract available
     
     
     October 2023
162. CHEN X, Wang D, Wang Z, Huang W, et al
     Identification of pyroptosis-related genes in NASH based on bioinformatic analysis.
     Biochem Biophys Res Commun. 2023;679:90-97.
     PubMed     Abstract available
     
     
     
163. ZHONG F, Wang Y
     YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1.
     Biochem Biophys Res Commun. 2023;679:98-109.
     PubMed     Abstract available
     
     
     
164. JUNG M, Ji E, Kang H, Kim C, et al
     The microRNA-195-5p/hnRNP A1 axis contributes to the progression of hepatocellular carcinoma by regulating the migration of cancer cells.
     Biochem Biophys Res Commun. 2023;686:149183.
     PubMed     Abstract available
     
     
     
165. JIN Q, Hu Y, Gao Y, Zheng J, et al
     Hhex and Prox1a synergistically dictate the hepatoblast to hepatocyte differentiation in zebrafish.
     Biochem Biophys Res Commun. 2023;686:149182.
     PubMed     Abstract available
     
     
     
166. DARIJANI MH, Aminzadeh A, Rahimi HR, Mandegary A, et al
     Evaluating the protective effect of metformin against diclofenac-induced oxidative stress and hepatic damage: In vitro and in vivo studies.
     Biochem Biophys Res Commun. 2023;685:149168.
     PubMed     Abstract available
     
     
     
167. SU H, Shu S, Tang W, Zheng C, et al
     ETV4 facilitates angiogenesis in hepatocellular carcinoma by upregulating MMP14 expression.
     Biochem Biophys Res Commun. 2023;684:149137.
     PubMed     Abstract available
     
     
     
168. GHEYBI F, Khooei A, Hoseinian A, Doagooyan M, et al
     Alleviation of acetaminophen-induced liver failure using silibinin nanoliposomes: An in vivo study.
     Biochem Biophys Res Commun. 2023;676:103-108.
     PubMed     Abstract available
     
     
     
169. JOUENNE A, Hamici K, Varlet I, Sourdon J, et al
     Relationship of cardiac remodeling and perfusion alteration with hepatic lipid metabolism in a prediabetic high fat high sucrose diet female rat model.
     Biochem Biophys Res Commun. 2023;682:207-215.
     PubMed     Abstract available
     
     
     
170. KIM J, Choi A, Kwon YH
     Maternal low-protein diet alters hepatic lipid accumulation and gene expression related to glucose metabolism in young adult mouse offspring fed a postweaning high-fat diet.
     Biochem Biophys Res Commun. 2023;682:193-198.
     PubMed     Abstract available
     
     
     
171. SUN G, Wei Y, Zhu J, Zheng S, et al
     The transcription factor T-bet promotes the pathogenesis of nonalcoholic fatty liver disease by upregulating intrahepatic inflammation.
     Biochem Biophys Res Commun. 2023;682:266-273.
     PubMed     Abstract available
     
     
     September 2023
172. ABRAHAMS Y, Willmer T, Patel O, Samodien E, et al
     A high fat, high sugar diet induces hepatic Peroxisome proliferator-activated receptor gamma coactivator 1-alpha promoter hypermethylation in male Wistar rats.
     Biochem Biophys Res Commun. 2023;680:25-33.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.